Tarek Assi
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Cancer Diagnosis and Treatment
-
- Sarcoma Diagnosis and Treatment
Papers in
-
- Sarcoma Diagnosis and Treatment 11
- Renal cell carcinoma treatment 4
- Oncology 32
- Cancer Immunotherapy and Biomarkers 9
- COVID-19 and healthcare impacts 5
- Co-authors
- Elie Rassy (54 shared papers)Joseph Kattan (46 shared papers)Olivier Mir (7 shared papers)Nicholas Pavlidis (9 shared papers)Marwan Ghosn (18 shared papers)Fadi El Karak (15 shared papers)Ziad Bakouny (12 shared papers)Salem Chouaı̈b (1 shared paper)
- Journals
- Critical Reviews in Oncology/Hematology (5 papers)Future Oncology (4 papers)Anti-Cancer Drugs (3 papers)Supportive Care in Cancer (3 papers)Cancer Treatment Reviews (3 papers)
- Partner nations
- LebanonFranceUnited States
In The Last Decade
Tarek Assi
79 papers receiving 962 citations
Peers
Comparison fields: 5 of 92
- Oncology 345
- Pulmonary and Respiratory Medicine 269
- Genetics 74
- Cancer Research 95
- Reproductive Medicine 48
Countries citing papers authored by Tarek Assi
This map shows the geographic impact of Tarek Assi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tarek Assi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tarek Assi more than expected).
Fields of papers citing papers by Tarek Assi
This network shows the impact of papers produced by Tarek Assi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tarek Assi. The network helps show where Tarek Assi may publish in the future.
Co-authors
The 25 scholars most cited alongside Tarek Assi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 85 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 73 | |
| 2 | 2021 | 63 | |
| 3 | 2017 | 57 | |
| 4 | 2020 | 45 | |
| 5 | 2021 | 44 | |
| 6 | 2022 | 44 | |
| 7 | 2020 | 38 | |
| 8 | 2020 | 36 | |
| 9 | 2016 | 28 | |
| 10 | 2018 | 28 | |
| 11 | 2020 | 25 | |
| 12 | 2019 | 25 | |
| 13 | 2015 | 24 | |
| 14 | 2016 | 24 | |
| 15 | 2018 | 20 | |
| 16 | 2021 | 19 | |
| 17 | 2018 | 17 | |
| 18 | 2020 | 14 | |
| 19 | 2021 | 14 | |
| 20 | 2021 | 14 |
About Tarek Assi
Tarek Assi is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Molecular Biology and Genetics, having authored 85 papers that have together received 971 indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (11 papers), Cancer Immunotherapy and Biomarkers (9 papers), Radiomics and Machine Learning in Medical Imaging (6 papers), COVID-19 and healthcare impacts (5 papers), Glioma Diagnosis and Treatment (5 papers), Renal cell carcinoma treatment (4 papers), Cardiac tumors and thrombi (4 papers) and Ovarian cancer diagnosis and treatment (4 papers). The work is most often cited by research in Oncology (345 citations), Pulmonary and Respiratory Medicine (269 citations), Genetics (74 citations), Cancer Research (95 citations) and Reproductive Medicine (48 citations). Tarek Assi has collaborated with scholars based in Lebanon, France and United States. Frequent co-authors include Elie Rassy, Joseph Kattan, Olivier Mir, Nicholas Pavlidis, Marwan Ghosn, Fadi El Karak, Ziad Bakouny, Salem Chouaı̈b, Ali N. Chamseddine and Tony Ibrahim. Their work appears in journals such as Critical Reviews in Oncology/Hematology, Future Oncology, Anti-Cancer Drugs, Supportive Care in Cancer and Cancer Treatment Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.